Your stakeholders are key – satisfy all their needs at North America's leading market access and real-world evidence summit.
In today’s complex healthcare environment, meeting the needs of payers, patients and decision-makers is a challenging but crucial task! The only companies to succeed will be those to fully embrace the potential of data and demonstrate the real-value of their drugs.
That’s why Data, Evidence and Access Summit 2017 (Nov 13-14) returns to Philadelphia for a 7th year, bringing with it two days of unmissable insights from the industry's leading market access and real-world evidence experts. On the first day - how to define and deliver value to a range of key stakeholders; while on day two we refine our focus to explore innovative uses of RWE across the company and take a detailed look into new outcomes-based pricing models and access strategies.
This is the only place pharma, payers and stakeholders come together to collaborate and drive the change towards a value-based healthcare system.